Global Point-of-Care or Rapid Testing Market By Product Type (Blood Glucose Testing, Infectious Diseases Testing) And By End-Users/Application (Clinics, Hospitals) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

  • AMR-982620
  • April 2021
  • Medical Devices
  • 152 Pages

Report Preview

The Point-of-Care or Rapid Testing Market research report comprises of an overall in depth-analysis such as market drivers, opportunities, restraints, latest developments and trends, segmentation of the market, competitive analysis, global as well as regional analysis by showcasing how each of these factors can improve the further growth of the market on an overall perspective. The report also showcases the overall market value which includes the historic data (2018-2019) and forecast data (2020-2028) generated through the revenue (USD Mn)

The Point-of-Care or Rapid Testing Market has been valued at US$ xx Mn in the year 2020 and is anticipated to attain US$ xx Mn by the year 2028 along with a CAGR of xx%

Point-of-Care or Rapid Testing Report’s Assessment
The research report is formulated such that it offers a deep understating on the market drivers that are assimilating the growth of the market, the market opportunities that are going to provide future growth factors for the market and the market restraints which showcase the reasons as to why the market can get hampered and dissimilated. All these factors are considered keeping in view the historic and forecast analysis which can enlighten the above mentioned factors.

Thereby at a glance a reader can understand all the factors and prospects of the Point-of-Care or Rapid Testing market and how it can assimilate and dissimilate based on each of the factors and figures mentioned in the report
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2019
Forecast Period Covered 2019 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Product Type Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy and Fertility Testing, Blood Gas/Electrolytes Testing, Urinalysis Testing, Others
Applications Clinics, Hospitals, Laboratory, Others
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Companies Covered Roche, Abbott, Johnson & Johnson, Siemens Healthcare, Danaher, Ascensia, Bio-Rad Laboratories, BioMerieux, ARKRAY, Nova Biomedical, Trividia Health, Quidel, Accriva, OraSure Technologies, Helena Laboratories, A. Menarini Diagnostics, Abaxis (Zoetis), Ortho Clinical Diagnostics, Phamatech, Chembio Diagnostics, Sinocare, Wondfo, Yuwell, Runbio, KHB, Wuhan EasyDiagnosis Biomedicine, DAAN GENE
 
Point-of-Care or Rapid Testing Market Competitive and Premeditated Analysis
In the Point-of-Care or Rapid Testing report major factors such latest tactical developments, competitors, research and development, participation of each region in the market and the competition among them, the latest news regarding company acquisitions and product launch, revenue of the competitors as well as the key offerings they provide all these factors are mentioned in the report with reasons to justify and understand them in depth.

The readers and purchaser of the Point-of-Care or Rapid Testing research report can gain a comprehensive understanding of the market competition, the revenue of each major players and their contribution towards the market, attractive proposition analysis is provided in the report which sub divides the segments with respect to the largest segment that has contributed to the market growth and the fastest growing segment based on the size of the market as well as its overall appeal.
 
Point-of-Care or Rapid Testing Market Segmentation Analysis:
The Point-of-Care or Rapid Testing market is segmented into various sections such as product types, applications as well as end users and regions. Each of the segment is explained in brief along with the revenue it generates for the market based on the historic and forecast data by highlighting the largest segment and the fastest growing segment with reasons to justify it.

Segmentation based on type includes Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy and Fertility Testing, Blood Gas/Electrolytes Testing, Urinalysis Testing, Others   

The application segment includes   Clinics, Hospitals, Laboratory, Others

Major Key Players for Global Point-of-Care or Rapid Testing Market:
The Point-of-Care or Rapid Testing market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Roche, Abbott, Johnson & Johnson, Siemens Healthcare, Danaher, Ascensia, Bio-Rad Laboratories, BioMerieux, ARKRAY, Nova Biomedical, Trividia Health, Quidel, Accriva, OraSure Technologies, Helena Laboratories, A. Menarini Diagnostics, Abaxis (Zoetis), Ortho Clinical Diagnostics, Phamatech, Chembio Diagnostics, Sinocare, Wondfo, Yuwell, Runbio, KHB, Wuhan EasyDiagnosis Biomedicine, DAAN GENE
 
The Point-of-Care or Rapid Testing market report showcases vast potentials of growth and assimilation which is going to provide the industry numerous opportunities to grow and generate revenue by understanding the segments and which segment is a potential part to increase the disposable income in the present and upcoming years.

Regional Analysis of the Point-of-Care or Rapid Testing market:
The Point-of-Care or Rapid Testing market is dived based on different regions such as North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. And the analysis of each region is provided by highlighting the largest contribution region, the fastest growing region and the factors that is keeping the market active in the other regions is also mentioned in depth. Each regional segment also comprises of the revenue each segment holds in a specific region with reasons to justify the values.

The Global segmentation of the Point-of-Care or Rapid Testing market:
By Type:
  • Blood Glucose Testing
  • Infectious Diseases Testing
  • Cardiac Markers Testing
  • Coagulation Testing
  • Pregnancy and Fertility Testing
  • Blood Gas/Electrolytes Testing
  • Urinalysis Testing
  • Others

By Application
  • Clinics
  • Hospitals
  • Laboratory
  • Others

By Regions:
  • North America (U.S and Canada)
  • Europe (U.K., Germany and France)
  • Asia Pacific (China, India and Japan)
  • Latin America (Mexico and Brazil)
  • Middle East and Africa (GCC Countries and South Africa)
 


 
Major Factors Included and highlighted in the Point-of-Care or Rapid Testing report are as follows:
  • The overall market value along with historic and future data analysis.
  • The Growth drivers, opportunities and restraints are mention in detail.
  • The size of the entire Point-of-Care or Rapid Testing market on a global perspective.
  • The CAGR value of the overall market from 2020 to 2028.
  • COVID-19 impact on the Point-of-Care or Rapid Testing market and how it is coping up with the situation.
  • Major competitors and their contribution towards the market.
  • The segmentation analysis is included which provides a clear picture of the market bifurcation.
  • Tables and graphs that can easily been understood at a glance
  • Latest trends and news related to the Point-of-Care or Rapid Testing market is included in the report.
 
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Point-of-Care or Rapid Testing market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Point-of-Care or Rapid Testing market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Point-of-Care or Rapid Testing market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Point-of-Care or Rapid Testing market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Point-of-Care or Rapid Testing market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Roche
  • Abbott
  • Johnson & Johnson
  • Siemens Healthcare
  • Danaher
  • Ascensia
  • Bio-Rad Laboratories
  • BioMerieux
  • ARKRAY
  • Nova Biomedical
  • Trividia Health
  • Quidel
  • Accriva
  • OraSure Technologies
  • Helena Laboratories
  • A. Menarini Diagnostics
  • Abaxis (Zoetis)
  • Ortho Clinical Diagnostics
  • Phamatech
  • Chembio Diagnostics
  • Sinocare
  • Wondfo
  • Yuwell
  • Runbio
  • KHB
  • Wuhan EasyDiagnosis Biomedicine
  • DAAN GENE
  • Blood Glucose Testing
  • Infectious Diseases Testing
  • Cardiac Markers Testing
  • Coagulation Testing
  • Pregnancy and Fertility Testing
  • Blood Gas/Electrolytes Testing
  • Urinalysis Testing
  • Others
  • Clinics
  • Hospitals
  • Laboratory
  • Others

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summary
     2.1. Global Point-of-Care or Rapid Testing Market Snapshot
          2.1.1. Global Point-of-Care or Rapid Testing Market By Type,2019
               2.1.1.1.Blood Glucose Testing
               2.1.1.2.Infectious Diseases Testing
               2.1.1.3.Cardiac Markers Testing
               2.1.1.4.Coagulation Testing
               2.1.1.5.Pregnancy and Fertility Testing
               2.1.1.6.Blood Gas/Electrolytes Testing
               2.1.1.7.Urinalysis Testing
               2.1.1.8.Others
          2.1.2. Global Point-of-Care or Rapid Testing Market By Application,2019
               2.1.2.1.Clinics
               2.1.2.2.Hospitals
               2.1.2.3.Laboratory
               2.1.2.4.Others
          2.1.3. Global Point-of-Care or Rapid Testing Market By End-use,2019
          2.1.4. Global Point-of-Care or Rapid Testing Market By Geography,2019

3. Global Point-of-Care or Rapid Testing Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Point-of-Care or Rapid Testing Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Point-of-Care or Rapid Testing Market Size (US$), By Type, 2018 – 2028

5. Global Point-of-Care or Rapid Testing Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Point-of-Care or Rapid Testing Market Size (US$), By Application, 2018 – 2028

6. Global Point-of-Care or Rapid Testing Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Point-of-Care or Rapid Testing Market Size (US$), By End-use, 2018 – 2028

7. Global Point-of-Care or Rapid Testing Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Point-of-Care or Rapid Testing Market Analysis, 2018 – 2028 
          7.2.1. North America Point-of-Care or Rapid Testing Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Point-of-Care or Rapid Testing Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Point-of-Care or Rapid Testing Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Point-of-Care or Rapid Testing Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Point-of-Care or Rapid Testing Market Analysis, 2018 – 2028 
          7.3.1.  Europe Point-of-Care or Rapid Testing Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Point-of-Care or Rapid Testing Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Point-of-Care or Rapid Testing Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Point-of-Care or Rapid Testing Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Point-of-Care or Rapid Testing Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Point-of-Care or Rapid Testing Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Point-of-Care or Rapid Testing Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Point-of-Care or Rapid Testing Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Point-of-Care or Rapid Testing Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Point-of-Care or Rapid Testing Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Point-of-Care or Rapid Testing Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Point-of-Care or Rapid Testing Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Point-of-Care or Rapid Testing Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Point-of-Care or Rapid Testing Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Point-of-Care or Rapid Testing Market Analysis, 2018 – 2028 
          7.6.1.  MEA Point-of-Care or Rapid Testing Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Point-of-Care or Rapid Testing Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Point-of-Care or Rapid Testing Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Point-of-Care or Rapid Testing Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Point-of-Care or Rapid Testing Providers
        8.4.1 Roche
                8.1.1 Business Description
                8.1.2 Roche Geographic Operations
                8.1.3 Roche Financial Information
                8.1.4 Roche Product Positions/Portfolio
                8.1.5 Roche Key Developments
        8.4.2 Abbott
                8.2.1 Business Description
                8.2.2 Abbott Geographic Operations
                8.2.3 Abbott Financial Information
                8.2.4 Abbott Product Positions/Portfolio
                8.2.5 Abbott Key Developments
        8.4.3 Johnson & Johnson
                8.3.1 Business Description
                8.3.2 Johnson & Johnson Geographic Operations
                8.3.3 Johnson & Johnson Financial Information
                8.3.4 Johnson & Johnson Product Positions/Portfolio
                8.3.5 Johnson & Johnson Key Developments
        8.4.4 Siemens Healthcare
                8.4.1 Business Description
                8.4.2 Siemens Healthcare Geographic Operations
                8.4.3 Siemens Healthcare Financial Information
                8.4.4 Siemens Healthcare Product Positions/Portfolio
                8.4.5 Siemens Healthcare Key Developments
        8.4.5 Danaher
                8.5.1 Business Description
                8.5.2 Danaher Geographic Operations
                8.5.3 Danaher Financial Information
                8.5.4 Danaher Product Positions/Portfolio
                8.5.5 Danaher Key Developments
        8.4.6 Ascensia
                8.6.1 Business Description
                8.6.2 Ascensia Geographic Operations
                8.6.3 Ascensia Financial Information
                8.6.4 Ascensia Product Positions/Portfolio
                8.6.5 Ascensia Key Developments
        8.4.7 Bio-Rad Laboratories
                8.7.1 Business Description
                8.7.2 Bio-Rad Laboratories Geographic Operations
                8.7.3 Bio-Rad Laboratories Financial Information
                8.7.4 Bio-Rad Laboratories Product Positions/Portfolio
                8.7.5 Bio-Rad Laboratories Key Developments
        8.4.8 BioMerieux
                8.8.1 Business Description
                8.8.2 BioMerieux Geographic Operations
                8.8.3 BioMerieux Financial Information
                8.8.4 BioMerieux Product Positions/Portfolio
                8.8.5 BioMerieux Key Developments
        8.4.9 ARKRAY
                8.9.1 Business Description
                8.9.2 ARKRAY Geographic Operations
                8.9.3 ARKRAY Financial Information
                8.9.4 ARKRAY Product Positions/Portfolio
                8.9.5 ARKRAY Key Developments
        8.4.10 Nova Biomedical
                8.10.1 Business Description
                8.10.2 Nova Biomedical Geographic Operations
                8.10.3 Nova Biomedical Financial Information
                8.10.4 Nova Biomedical Product Positions/Portfolio
                8.10.5 Nova Biomedical Key Developments
        8.4.11 Trividia Health
                8.11.1 Business Description
                8.11.2 Trividia Health Geographic Operations
                8.11.3 Trividia Health Financial Information
                8.11.4 Trividia Health Product Positions/Portfolio
                8.11.5 Trividia Health Key Developments
        8.4.12 Quidel
                8.12.1 Business Description
                8.12.2 Quidel Geographic Operations
                8.12.3 Quidel Financial Information
                8.12.4 Quidel Product Positions/Portfolio
                8.12.5 Quidel Key Developments
        8.4.13 Accriva
                8.13.1 Business Description
                8.13.2 Accriva Geographic Operations
                8.13.3 Accriva Financial Information
                8.13.4 Accriva Product Positions/Portfolio
                8.13.5 Accriva Key Developments
        8.4.14 OraSure Technologies
                8.14.1 Business Description
                8.14.2 OraSure Technologies Geographic Operations
                8.14.3 OraSure Technologies Financial Information
                8.14.4 OraSure Technologies Product Positions/Portfolio
                8.14.5 OraSure Technologies Key Developments
        8.4.15 Helena Laboratories
                8.15.1 Business Description
                8.15.2 Helena Laboratories Geographic Operations
                8.15.3 Helena Laboratories Financial Information
                8.15.4 Helena Laboratories Product Positions/Portfolio
                8.15.5 Helena Laboratories Key Developments
        8.4.16 A. Menarini Diagnostics
                8.16.1 Business Description
                8.16.2 A. Menarini Diagnostics Geographic Operations
                8.16.3 A. Menarini Diagnostics Financial Information
                8.16.4 A. Menarini Diagnostics Product Positions/Portfolio
                8.16.5 A. Menarini Diagnostics Key Developments
        8.4.17 Abaxis (Zoetis)
                8.17.1 Business Description
                8.17.2 Abaxis (Zoetis) Geographic Operations
                8.17.3 Abaxis (Zoetis) Financial Information
                8.17.4 Abaxis (Zoetis) Product Positions/Portfolio
                8.17.5 Abaxis (Zoetis) Key Developments
        8.4.18 Ortho Clinical Diagnostics
                8.18.1 Business Description
                8.18.2 Ortho Clinical Diagnostics Geographic Operations
                8.18.3 Ortho Clinical Diagnostics Financial Information
                8.18.4 Ortho Clinical Diagnostics Product Positions/Portfolio
                8.18.5 Ortho Clinical Diagnostics Key Developments
        8.4.19 Phamatech
                8.19.1 Business Description
                8.19.2 Phamatech Geographic Operations
                8.19.3 Phamatech Financial Information
                8.19.4 Phamatech Product Positions/Portfolio
                8.19.5 Phamatech Key Developments
        8.4.20 Chembio Diagnostics
                8.20.1 Business Description
                8.20.2 Chembio Diagnostics Geographic Operations
                8.20.3 Chembio Diagnostics Financial Information
                8.20.4 Chembio Diagnostics Product Positions/Portfolio
                8.20.5 Chembio Diagnostics Key Developments
        8.4.21 Sinocare
                8.21.1 Business Description
                8.21.2 Sinocare Geographic Operations
                8.21.3 Sinocare Financial Information
                8.21.4 Sinocare Product Positions/Portfolio
                8.21.5 Sinocare Key Developments
        8.4.22 Wondfo
                8.22.1 Business Description
                8.22.2 Wondfo Geographic Operations
                8.22.3 Wondfo Financial Information
                8.22.4 Wondfo Product Positions/Portfolio
                8.22.5 Wondfo Key Developments
        8.4.23 Yuwell
                8.23.1 Business Description
                8.23.2 Yuwell Geographic Operations
                8.23.3 Yuwell Financial Information
                8.23.4 Yuwell Product Positions/Portfolio
                8.23.5 Yuwell Key Developments
        8.4.24 Runbio
                8.24.1 Business Description
                8.24.2 Runbio Geographic Operations
                8.24.3 Runbio Financial Information
                8.24.4 Runbio Product Positions/Portfolio
                8.24.5 Runbio Key Developments
        8.4.25 KHB
                8.25.1 Business Description
                8.25.2 KHB Geographic Operations
                8.25.3 KHB Financial Information
                8.25.4 KHB Product Positions/Portfolio
                8.25.5 KHB Key Developments
        8.4.26 Wuhan EasyDiagnosis Biomedicine
                8.26.1 Business Description
                8.26.2 Wuhan EasyDiagnosis Biomedicine Geographic Operations
                8.26.3 Wuhan EasyDiagnosis Biomedicine Financial Information
                8.26.4 Wuhan EasyDiagnosis Biomedicine Product Positions/Portfolio
                8.26.5 Wuhan EasyDiagnosis Biomedicine Key Developments
        8.4.27 DAAN GENE
                8.27.1 Business Description
                8.27.2 DAAN GENE Geographic Operations
                8.27.3 DAAN GENE Financial Information
                8.27.4 DAAN GENE Product Positions/Portfolio
                8.27.5 DAAN GENE Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Point-of-Care or Rapid Testing Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Point-of-Care or Rapid Testing Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Point-of-Care or Rapid Testing Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Point-of-Care or Rapid Testing Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Point-of-Care or Rapid Testing Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Point-of-Care or Rapid Testing Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Point-of-Care or Rapid Testing Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Point-of-Care or Rapid Testing Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Point-of-Care or Rapid Testing Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Point-of-Care or Rapid Testing Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Point-of-Care or Rapid Testing Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Point-of-Care or Rapid Testing Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Point-of-Care or Rapid Testing Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Point-of-Care or Rapid Testing Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Point-of-Care or Rapid Testing Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Point-of-Care or Rapid Testing Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Point-of-Care or Rapid Testing: Market Segmentation 
FIG. 2 Global Point-of-Care or Rapid Testing Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Point-of-Care or Rapid Testing Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Point-of-Care or Rapid Testing Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Point-of-Care or Rapid Testing Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Point-of-Care or Rapid Testing Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Point-of-Care or Rapid Testing Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Point-of-Care or Rapid Testing Providers, 2019
FIG. 11 Global Point-of-Care or Rapid Testing Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Point-of-Care or Rapid Testing Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Point-of-Care or Rapid Testing Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Point-of-Care or Rapid Testing Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Point-of-Care or Rapid Testing Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Point-of-Care or Rapid Testing Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Point-of-Care or Rapid Testing Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Point-of-Care or Rapid Testing Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Point-of-Care or Rapid Testing market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Point-of-Care or Rapid Testing Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Point-of-Care or Rapid Testing Market Value, By Segment1, 2018 – 2028
TABLE  North America Point-of-Care or Rapid Testing Market Value, By Segment2, 2018 – 2028
TABLE  North America Point-of-Care or Rapid Testing Market Value, By Country, 2018 – 2028
TABLE  Europe Point-of-Care or Rapid Testing Market Value, By Segment1, 2018 – 2028
TABLE  Europe Point-of-Care or Rapid Testing Market Value, By Segment2, 2018 – 2028
TABLE  Europe Point-of-Care or Rapid Testing Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Point-of-Care or Rapid Testing Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Point-of-Care or Rapid Testing Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Point-of-Care or Rapid Testing Market Value, By Country, 2018 – 2028
TABLE  Latin America Point-of-Care or Rapid Testing Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Point-of-Care or Rapid Testing Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Point-of-Care or Rapid Testing Market Value, By Country, 2018 – 2028
TABLE  MEA Point-of-Care or Rapid Testing Market Value, By Segment1, 2018 – 2028
TABLE  MEA Point-of-Care or Rapid Testing Market Value, By Segment2, 2018 – 2028
TABLE  MEA Point-of-Care or Rapid Testing Market Value, By Country, 2018 – 2028
TABLE  Roche: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Abbott: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Johnson & Johnson: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Siemens Healthcare: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Danaher: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Ascensia: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bio-Rad Laboratories: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  BioMerieux: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  ARKRAY: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Nova Biomedical: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Trividia Health: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Quidel: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Accriva: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  OraSure Technologies: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Helena Laboratories: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  A. Menarini Diagnostics: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Abaxis (Zoetis): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Ortho Clinical Diagnostics: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Phamatech: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Chembio Diagnostics: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sinocare: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Wondfo: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Yuwell: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Runbio: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  KHB: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Wuhan EasyDiagnosis Biomedicine: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  DAAN GENE: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Point-of-Care or Rapid Testing Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Point-of-Care or Rapid Testing Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Point-of-Care or Rapid Testing Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Point-of-Care or Rapid Testing Market, By Geography, 2019 (US$ Mn)
FIG.  Global Point-of-Care or Rapid Testing Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Point-of-Care or Rapid Testing Providers, 2016
FIG.  Global Point-of-Care or Rapid Testing Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Blood Glucose Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Infectious Diseases Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Cardiac Markers Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Coagulation Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Pregnancy and Fertility Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Blood Gas/Electrolytes Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Urinalysis Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Point-of-Care or Rapid Testing Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Clinics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Hospitals Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Laboratory Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Point-of-Care or Rapid Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Point-of-Care or Rapid Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Point-of-Care or Rapid Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Point-of-Care or Rapid Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Point-of-Care or Rapid Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Point-of-Care or Rapid Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Point-of-Care or Rapid Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Point-of-Care or Rapid Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Point-of-Care or Rapid Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Point-of-Care or Rapid Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Point-of-Care or Rapid Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Point-of-Care or Rapid Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Point-of-Care or Rapid Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Point-of-Care or Rapid Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Point-of-Care or Rapid Testing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Point-of-Care or Rapid Testing Market Value, 2018 – 2028, (US$ Mn)